Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Stem cells in preclinical spine studies.

Werner BC., Li X., Shen FH.

Narrative Review on Disc Degeneration, published in Spine J (2013) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Spine J (2013)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
24246748
DOI
10.1016/j.spinee.2013.08.031
Citations
10

Abstract (original English)

Background context The recent identification and characterization of mesenchymal stem cells have introduced a shift in the research focus for future technologies in spinal surgery to achieve spinal fusion and treat degenerative disc disease. Current and past techniques use allograft to replace diseased tissue or rely on host responses to recruit necessary cellular progenitors. Adult stem cells display long-term proliferation, efficient self-renewal, and multipotent differentiation. Purpose This review will focus on two important applications of stem cells in spinal surgery: spine fusion and the management of degenerative disc disease. Study design Review of the literature. Methods Relevant preclinical literature regarding stem cell sources, growth factors, scaffolds, and animal models for both osteogenesis and chondrogenesis will be reviewed, with an emphasis on those studies that focus on spine applications of these technologies. Results In both osteogenesis and chondrogenesis, adult stem cells derived from bone marrow or adipose show promise in preclinical studies. Various growth factors and scaffolds have also been shown to enhance the properties and eventual clinical potential of these cells. Although its utility in clinical applications has yet to be proven, gene therapy has also been shown to hold promise in preclinical studies. Conclusions The future of spine surgery is

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdultAdult Stem CellsAnimalsChondrogenesisHumansIntervertebral Disc DegenerationMesenchymal Stem Cell TransplantationModels, AnimalOsteogenesisSpinal Fusion

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research